chrisvoncsefalvay/vaers-outcomes huggingface dataset:
swelling in her arm pit/ swelling between her shoulder and her neck that was visible; It hurts and is very uncomfortable; off the injection site was higher up on her arm than normal; This is a spontaneous report from a contactable consumer (patient). A 59-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), first dose via an unspecified route of administration on 09Apr2021 (lot number: EW0162) as single dose for COVID-19 immunisation. The patient medical history included receiving prior flu and shingles vaccine. The patient's concomitant medications were not reported. As reported, the patient received the vaccine of the Pfizer Covid 19 vaccine on Friday. She stated she had swelling in her arm pit and it was uneasy to put her arm by her side. It hurt and was very uncomfortable. She kind of had to keep her arm away from her body. She also reported swelling between her shoulder and her neck that was visible. When she took the band aid, off the injection site was higher up on her arm than normal. The report was reported as non-serious. The outcome of the events was unknown.    No follow-up attempts are needed. No further information is expected.
This spontaneous report as receive from a registered nurse concerning to unspecified number of patients of unknown age and gender. No concurrent conditions, medical history or allergy/drug reactions were reported. On an unknown date, the patients' were vaccinated with improperly stored doses of ZOSTAVAX, lot # L024998, expiration date: 06-OCT-2016, (dose, route and anatomical location were unspecified). No concomitant medications were reported. No adverse symptoms were reported. Additional information has been requested.
arm pain full body aches with pain in neck, shoulder, feet, hand, ribs, hips fatigue my liver feels like it is aching
Information has been received from a health professional concerning a female who on 31MAY2000 was vaccinated with a dose of varicella virus vaccine live. Concomitant therapy the same day included measles virus vaccine live, poliovirus vaccine inactivated and tuberculin purified protein derivative. Subsequently, the patient developed mild chickenpox after a sibling had chickenpox. The parent of the child reported this to the nurse on 08OCT2003. Unspecified medical attention was sought. There was no product quality complaint involved. The reporter indicated that two other patient's had similar experiences following exposure to varicella virus vaccine live. Additional information has been requested.
fainting per patient, immediately after receiving the vaccination . Pt then started having  symptoms of weakness, fatigue, dizziness.. That evening she started to feel week and had little energy . Symptoms were progressive and then on 9/11, she started having weakness with sob and chest pain, and fatigue. she was taken to ER and  patient states  doctor was concerned about myocarditis and advised her not to take second vaccine. on 9/13 she was seen at the clinic with sx of  mild headache, full frontal region, mild nausea, and fatigue. She was no longer having chest pain, sob and states she feels a little better today compared to yesterday. She had another f/u on 9/17 at the clinic and felt normal all symptoms had resolved.
Hiberix / reconstituted with an sterile diluent; Hiberix / reconstituted with an sterile diluent; This case was reported by a nurse via a representative and described the occurrence of wrong solution used in drug reconstitution in a 12-month-old female patient who received Hib (Hiberix) (batch number PJ7ER, expiry date 13th November 2022) for prophylaxis.   On 20th August 2021, the patient received the 3rd dose of Hiberix. On 20th August 2021, unknown after receiving Hiberix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional details were provided as the reporter stated that, Hiberix was reconstituted with an sterile diluent and administered to a female patient.  Nurse states a patient was given a dose of Hiberix that was reconstituted using the saline for MMR vaccine instead of the diluent that comes with the Hiberix, which led to wrong solution used in drug reconstitution, and inappropriate dose of vaccine administered. The Nurse was not at the primary office location where vaccine administration error occurred and does not have any further details available at the time of this call. The reporter consented to follow up. This case was linked with case US2021176206, reported by same reporter for different patient.
nerve pain from the neck; spine trouble; shoulder impingement; Her range of motion was limited as patient can move her arm but cannot move side to side; Initial information regarding an unsolicited valid non-serious case was received from a consumer/non-health care professional via global medical information (GMI) (Reference number- 00489616) and transmitted to Sanofi on 23-Feb-2021.  This case involves female patient (age unspecified) who experienced nerve pain from the neck (neuralgia), spine trouble (spinal pain), shoulder impingement (rotator cuff syndrome) and her range of motion was limited as patient can move her arm but cannot move side to side (mobility decreased), after she received INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  It was reported that, patient had a preexisting neck condition (Neck discomfort/Musculoskeletal discomfort).  Past medical treatment, vaccination, family history and concomitant medication were not reported.  On 29-Sep-2020, the patient received a 0.5 mL dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [lot number, expiry date not reported] via an unknown route at the shoulder (as per reporter: too high on her shoulder) for prophylactic vaccination.  On an unknown date, the patient had non-serious nerve pain from the neck (neuralgia), spine trouble (spinal pain), shoulder impingement (rotator cuff syndrome) and her range of motion was limited as patient can move her arm but cannot move side to side (mobility decreased), (unknown latency) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  Patient believes that, the vaccination was given too high to her shoulder and till the time of reporting she was suffering to it and this was related to the discomfort she is experiencing.  Also, patient reported that, physicians were misdiagnosing her situation.    Relevant laboratory test results included: Electromyogram - On an unknown date: EMG indicates that the patient's trouble was not coming from her spine.   Patient reported that, trouble coming from her shoulder and for EMG thought, maybe there was carpal tunnel, but she wore a hand thing for several weeks and that wasn't it.  She got a cortisone shot in her shoulder and that provided relieve for the past couple of days.   For mobility decrease patient reported that, it was from the flu shot and she had pre-existing conditions which was frustrating for her.   At the time of reporting, the patient was not recovered from the reported events.   At the time of reporting, the patient wanted to know data about the effects of FLUBLOK administration that was too high on the shoulder and if FLUBLOK contain latex or un-natural latex.   The information provided was not entirely clear to the consultant but is being documented to the best that can be determined.  There will be no information available on the batch number for this case.
Patient presented in good health and was wanting her vaccine. After 30 seconds to 1 minute of receiving the vaccine, patient complained of feeling lightheaded and soon fainted. She was sitting down in a chair at the time and I caught her before she could fall and hit the ground. I lowered her to the ground and elevated her feet. I had my staff call 911 to have paramedics come and evaluate her. She soon regained consciousness and was talkative with me. She mentioned that she never had a history of fainting before and that she had barely eaten in the morning before the shot. Once paramedics arrived, they lowered her feet and helped her sit up in another chair. She was released from their care several minutes later.
Increasing fatigue and lethargy, short of breath after shot. Trip to urgent care  week later resulted in ambulance taking him to emergency room   Diagnosed with Atrial fibrillation and resulting clot in heart. Has had a second hospitalization since then. Zero heart problems prior. Now considered a heart failure patient.
This is a spontaneous report received from a contactable reporter(s) (Pharmacist). A 5-year-old male patient received BNT162b2 (BNT162B2), on 08Aug2022 at 15:00 as dose 2, single (Lot number: FL8095) at the age of 5 years intramuscular, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (lot number=FL8095, route=Intramuscular, administration time=03:30 PM, vaccine location=Left arm), administration date: 13Jul2022, when the patient was 5-year-old, for COVID-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 09Aug2022 at 05:00, outcome "recovering", described as "Fever (101.5 F)"; PAIN IN EXTREMITY (non-serious) with onset 09Aug2022 at 05:00, outcome "recovering", described as "sore arm". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia, pain in extremity. Additional information: no other vaccine in four weeks. No COVID prior vaccination and no COVID tested post vaccination. The patient had no known allergies. The patient received Tylenol as treatment.
Body chills, fever, severe joint and body pain and aches, nausea, severe headache, dehydration, sinus dryness, lip dryness, fatigue.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Sep2022 as dose 5 (booster), single (Lot number: GH9702) at the age of 75 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: SYNTHROID; LOSARTAN. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of covid-19.  Clinical course: It was reported that patient had Other medications in two weeks (Synthroid, Losartan). Patient was treated for covid-19 with Paxlovid.
Place of injection site began to get really sore about 5/8/2021 and lasted until about 5/14/2021. I used ice and took Tylenol and/or ibuprofen. No swelling but the Tylenol and ibuprofen worked for the pain
September 9th, 2021 swelling to ears, hives on arms, itching all over body; presented to local ER, treated with a shot, possibly benadryl, per pt and oral benadryl September 10th, 2021 symptoms did not improve, presented again to ER, was prescribed Claritin to take on a set schedule prescribed by the ER physician September 11th, 2021, continued to have swelling, hives and itching.  Patient states she went back to the ER.  States she continued to itch for a month. Complains that palms of hands are still red.  November 23, 2021 patient reports nose bleed while at home watching TV. EMS was called, unable to stop nose bleed, patient was taken to the ER, nose bleed was stopped with the insertion of foam product for nosebleeds.
2 months After the second vaccine administered on August 4, 2021, I have been presenting delays in menstruation. In the month of November the menstruation did not appear, in the month of December it was only spots and in the month of January 2022 the menstruation appeared on the 6th with extremely strong pain, abundant blood and around 14 clots in the day January 7th. On the 8th at night he did not present any menstruation at all. Adding to this that when I am not on my menstruation days I am in pain practically the whole month, a strong pain as if my menstruation was going to come but it does not come because it is not even the time. I was always regular in my period until the second dose was administered on August 4, 2021
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. Medical history, concomitant therapy and concurrent conditions were not reported. In August 2016 (also reported as 22-AUG-2016 until 30-AUG-2016) the patients were vaccinated with GARDASIL 9 (Lot number, expiration date, concentration, dose, frequency and route of administration were not provided), which was improperly stored on 30-AUG-2016, this excursion was detected due to digital data logger. It was also reported that the GARDASIL 9 was exposed to a temperature of 34 Fahrenheit degrees for 56 hours. No adverse effects were reported. Additional information has been requested.
Patient states she began having  abdominal cramping  and diarrhea 1 hour after getting her first injection then again with the second injection. She states the cramping and diarrhea were more severe after the second injection. She also states she feels cramping, gassy, weak, and fatigued since having her second injection on the 17th.  She states she explained her symptoms to the person whom was giving the injections and was told that she should take it any way.
I am relatively certain that I was exposed to COVID-19 on 4/08/22. I was at an indoor performance with no mask. I began to see symptoms on 04/10/22 with fever, congestion, weakness, sore muscles and joints. I took an at home test on the 11th which was positive. After that I got a prescription for 5 days of Paxlovid on Tuesday, my fever broke and the tests were negative. But I was still experiencing nasal congestion which turned into chest congestion. I subsequently went to see the doctor 4/23/22. He prescribed 20mg of Prednisone twice daily for 5 days along with an Albuterol inhaler and a Fluticasone Fumarate inhaler. I'm still experiencing cough, nasal congestion, headache, and itchy throat. I suffer from allergies, but I have not had allergy symptoms this bad in the past.
Arm were ZOSTAVAX was given got warm, swollen & sore.  It was the size of a half dollar
VISION TURNED ALL WHITE; ARM SORENESS; CHILLS; PAIN IN HIP JOINTS; FEVER; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: Unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On APR-2021, the subject experienced vision turned all white. On APR-2021, the subject experienced arm soreness. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced pain in hip joints. On APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the arm soreness, fever, chills, pain in hip joints and vision turned all white was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
This spontaneous report as received from a Registered Nurse refers to an unspecified number of patients of unknown age and gender. The patients' pertinent medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (lot # L038018 with expiry date on 13-SEP-2017, lot# L048848 with expiry date on 09-AUG-2018 and lot# M010671 with expiry date on 02-JUN-2018) (dose and route of administration were not reported). No adverse symptoms were reported. No product quality complaint was involved. Additional information has been requested.
Patient developed Bell's Palsy RIGHT side of his face 12 days after receiving the booster shot
Patient received Flucelvax 0.5 ML in office 9/29/2021. He did not report he was already given the flu vaccine. It was after, when we received medication records from his pharmacy that it indicated that flu vaccine was given 9/7/2021. Called pharmacy who confirmed information. Seqirus was also contacted and informed, as requested by VAERS representative. Today was  Pt's first office visit with us.  Patient waited 25 minutes after recieving the vaccine, did not present any symptoms and was discharge. Pt was called shortly after and notified of the incident. He was advised to look out for symptoms, he can call us and/or to go to the hospital/ED if severe symptoms appear.
Initial report was received from a consumer on 08 October 2012, who is also the patient. A 52-year-old female patient received an intramuscular injection in the deltoid of IMOVAX Rabies, lot number unknown, on 10 September 2012. The patient also received post exposure prophylaxis with a Rabies Vaccine and Human Rabies Immune Globulin (manufacturers and lot numbers unknown; routes, sites of administration, and dates given not reported). On 13 September 2012, the patient experienced nerve pain, tingling, weakness, and pressure down the right side. The patient went to the emergency department three times. The physician diagnosed the patient with "vaccine serum sickness" and told her it would resolve in a month. She later developed the same symptoms down her left side with constant pressure in her skin, which was puffy, sensitive, and developed welts if she scratched it. Patient was taking over-the-counter antihistamines and ibuprofen per physician. Patient claimed the symptoms were getting worse. The patient's outcome was not recovered. Documents held by sender: None.
swollen lymph nodes on left side of neck; first dose on 27Dec2020 and second dose on 07Jan2021; This is a spontaneous report from a contactable nurse (patient herself). A 63-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection; batch/lot number and expiration date were unknown), via an unspecified route of administration on the left arm on 07Jan2021 at a single dose for COVID-19 immunization. The patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection; batch/lot number and expiration date were unknown), via an unspecified route of administration on the left arm on 27Dec2020 at 16:45. Both doses were administered at the hospital. Relevant medical history included non-insulin-dependent diabetes mellitus (NIDDM), hypertension (HTN), hypersensitivity lung disease (HLD), hyperthyroid, and Graves. The patient had no known allergies. Concomitant medications included empagliflozin (JARDIANCE), metformin, methimazole, cetirizine hydrochloride (ZYRTEC), and montelukast sodium (SINGULA). The patient was not pregnant. The patient had no other vaccine in four weeks. The patient had no Covid prior vaccination. The patient received her first dose on 27Dec2020 and second dose on 07Jan2021. The patient had an adverse event on the next eve of the second (2nd) vaccine. On 08Jan2021 at 22:00, she experienced swollen lymph nodes on left side of neck. The swelling was going down incrementally as she took paracetamol (TYLENOL) 1000 mg per oral (p.o.) daily. The patient underwent Covid test via nasal swab post vaccination on 29Dec2020, which resulted negative. The patient was recovering from the event.  Information on the batch/lot number has been requested.
Within 5 minutes of receiving 3 vaccines - MENACTRA, ADACEL, and GARDASIL, pt developed a macular/papular rash L arm and trunk. BENADRYL dispensed - rash resolving within about 15-20 min. No wheeze. No h/o latex allergy.
Patient presented with a swollen red arm (area larger than a softball). Patient complained of it being painful, warm and itchy.  It presented later that day after the vaccination was given and has slowly been getting smaller. I advised patient to monitor and continue to ice area as needed. I recommended an oral antihistamine to help with the itching.  She said she would follow up with me to let me know if there is any change.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient (pt) of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 01-JUN-2010, pt was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, and route of administration were not specified), as prescribed and/or administered by a healthcare provider for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to pt's zoster vaccine live (ZOSTAVAX) inoculation on an unknown date, pt was treated by a healthcare provider for shingles. As a direct and proximate result of pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, pt has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX). The outcome of the event was not recovered.